2 ms·
You're assuming that most of the "extra" money goes back in research and not to shareholders and management bonuses Given how pharma companies operate, I kinda
by raverbashing 4y ago
You're assuming that most of the "extra" money goes back in research and not to shareholders and management bonuses
Given how pharma companies operate, I kinda doubt it.
- mjewkes 4y agoNo assumptions. The rand article addresses that directly.